| Year |
Citation |
Score |
| 2016 |
Holland SJ, Owyang AM, Braselmann S, Lamagna C, Yi S, Young C, Frances R, Bagos A, Chan M, Tai E, Siu S, Park G, Lau D, Duan M, Kolluri R, et al. Abstract B060: Small molecule inhibitors of the anti-inflammatory TAM receptor MerTK Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-B060 |
0.435 |
|
| 2016 |
Holland SJ, Owyang AM, Yi S, Young C, Braselmann S, Frances R, Bagos A, Tai E, Siu S, Park G, Lau D, Duan M, Kolluri R, Bhamidipati S, Darwish I, et al. Abstract 4869: Small molecule inhibitors of the anti-inflammatory TAM receptor MerTK Cancer Research. 76: 4869-4869. DOI: 10.1158/1538-7445.Am2016-4869 |
0.468 |
|
| 2012 |
Haarberg KM, Kaosaard K, Li J, Heinrichs J, Bronk C, Owyang AM, Masuda E, Anasetti C, Beg A, Yu X. Genetic and Pharmacologic Inhibition of PKCθ and PKCα Prevents Acute Gvhd While Sparing GVL Activity in Mice. Blood. 120: 3000-3000. DOI: 10.1182/Blood.V120.21.3000.3000 |
0.442 |
|
| 2010 |
Roell MK, Issafras H, Bauer RJ, Michelson KS, Mendoza N, Vanegas SI, Gross LM, Larsen PD, Bedinger DH, Bohmann DJ, Nonet GH, Liu N, Lee SR, Handa M, Kantak SS, ... ... Owyang AM, et al. Kinetic approach to pathway attenuation using XOMA 052, a regulatory therapeutic antibody that modulates interleukin-1beta activity. The Journal of Biological Chemistry. 285: 20607-14. PMID 20410301 DOI: 10.1074/Jbc.M110.115790 |
0.341 |
|
| 2010 |
Owyang AM, Maedler K, Gross L, Yin J, Esposito L, Shu L, Jadhav J, Domsgen E, Bergemann J, Lee S, Kantak S. XOMA 052, an anti-IL-1{beta} monoclonal antibody, improves glucose control and {beta}-cell function in the diet-induced obesity mouse model. Endocrinology. 151: 2515-27. PMID 20332197 DOI: 10.1210/En.2009-1124 |
0.32 |
|
| 2007 |
Kleinschek MA, Owyang AM, Joyce-Shaikh B, Langrish CL, Chen Y, Gorman DM, Blumenschein WM, McClanahan T, Brombacher F, Hurst SD, Kastelein RA, Cua DJ. IL-25 regulates Th17 function in autoimmune inflammation. The Journal of Experimental Medicine. 204: 161-70. PMID 17200411 DOI: 10.1084/Jem.20061738 |
0.301 |
|
| 2006 |
Owyang AM, Zaph C, Wilson EH, Guild KJ, McClanahan T, Miller HR, Cua DJ, Goldschmidt M, Hunter CA, Kastelein RA, Artis D. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. The Journal of Experimental Medicine. 203: 843-9. PMID 16606667 DOI: 10.1084/Jem.20051496 |
0.336 |
|
| 2005 |
Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 23: 479-90. PMID 16286016 DOI: 10.1016/J.Immuni.2005.09.015 |
0.321 |
|
| 2004 |
Lieberman LA, Cardillo F, Owyang AM, Rennick DM, Cua DJ, Kastelein RA, Hunter CA. IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12. Journal of Immunology (Baltimore, Md. : 1950). 173: 1887-93. PMID 15265921 DOI: 10.4049/Jimmunol.173.3.1887 |
0.303 |
|
| 2002 |
Hsia CY, Cheng S, Owyang AM, Dowdy SF, Liou HC. c-Rel regulation of the cell cycle in primary mouse B lymphocytes. International Immunology. 14: 905-16. PMID 12147627 DOI: 10.1093/Intimm/Dxf055 |
0.637 |
|
| 2001 |
Owyang AM, Tumang JR, Schram BR, Hsia CY, Behrens TW, Rothstein TL, Liou HC. c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis. Journal of Immunology (Baltimore, Md. : 1950). 167: 4948-56. PMID 11673501 DOI: 10.4049/Jimmunol.167.9.4948 |
0.552 |
|
| 1998 |
Tumang JR, Owyang A, Andjelic S, Jin Z, Hardy RR, Liou ML, Liou HC. c-Rel is essential for B lymphocyte survival and cell cycle progression. European Journal of Immunology. 28: 4299-312. PMID 9862367 DOI: 10.1002/(Sici)1521-4141(199812)28:12<4299::Aid-Immu4299>3.0.Co;2-Y |
0.733 |
|
| Show low-probability matches. |